S10 Ep143: The New Formula (Abbott Laboratories)
Summary
This episode investigates the 2025 infant botulism outbreak linked to By Heart formula, tracing the startup’s rise during the 2022 Abbott recall and subsequent regulatory failures. It contrasts By Heart’s rapid expansion with the long-standing negligence of Abbott Laboratories, whose Sturgis plant was found to be unsanitary and linked to a nationwide formula shortage. The narrative highlights how corporate consolidation, regulatory delays, and a culture of prioritizing profits over safety created a fragile supply chain vulnerable to crisis.
Listen ad-free on Castria